HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.64
Day range
$0.65 - $0.69
Year range
$0.46 - $0.87
Market cap
52.27M CAD
Avg Volume
39.87K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.48M | 107.26% |
Net income | -1.55M | -109.77% |
Net profit margin | — | — |
Earnings per share | -0.02 | — |
EBITDA | -1.47M | -106.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 700.00K | 29.39% |
Total assets | 2.44M | 12.49% |
Total liabilities | 680.00K | -65.67% |
Total equity | 1.76M | — |
Shares outstanding | 78.01M | — |
Price to book | 32.00 | — |
Return on assets | -122.54% | — |
Return on capital | -156.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.55M | -109.77% |
Cash from operations | -1.74M | -174.09% |
Cash from investing | -45.00K | -2.27% |
Cash from financing | 177.00K | 96.67% |
Net change in cash | -1.82M | -202.82% |
Free cash flow | -1.31M | 16.13% |
About
Founded
2011
Website
Employees
12
